List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Endoparasiticide Product Introduction
1.2 Market by Type
1.2.1 Global Endoparasiticide Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Ear Tags
1.2.3 Tablets
1.2.4 Injectables
1.2.5 Feed Additives
1.3 Market by Application
1.3.1 Global Endoparasiticide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Veterinary Hospitals or Clinics
1.3.3 Animal Farms
1.3.4 Home Care Settings
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Endoparasiticide Sales Estimates and Forecasts 2017-2028
2.2 Global Endoparasiticide Revenue Estimates and Forecasts 2017-2028
2.3 Global Endoparasiticide Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Endoparasiticide Sales by Region
2.4.1 Global Endoparasiticide Sales by Region (2017-2022)
2.4.2 Global Sales Endoparasiticide by Region (2023-2028)
2.5 Global Endoparasiticide Revenue by Region
2.5.1 Global Endoparasiticide Revenue by Region (2017-2022)
2.5.2 Global Endoparasiticide Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Endoparasiticide Sales by Manufacturers
3.1.1 Global Top Endoparasiticide Manufacturers by Sales (2017-2022)
3.1.2 Global Endoparasiticide Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Endoparasiticide in 2021
3.2 Global Endoparasiticide Revenue by Manufacturers
3.2.1 Global Endoparasiticide Revenue by Manufacturers (2017-2022)
3.2.2 Global Endoparasiticide Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Endoparasiticide Revenue in 2021
3.3 Global Endoparasiticide Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Endoparasiticide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Endoparasiticide Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Endoparasiticide Sales by Type
4.1.1 Global Endoparasiticide Historical Sales by Type (2017-2022)
4.1.2 Global Endoparasiticide Forecasted Sales by Type (2023-2028)
4.1.3 Global Endoparasiticide Sales Market Share by Type (2017-2028)
4.2 Global Endoparasiticide Revenue by Type
4.2.1 Global Endoparasiticide Historical Revenue by Type (2017-2022)
4.2.2 Global Endoparasiticide Forecasted Revenue by Type (2023-2028)
4.2.3 Global Endoparasiticide Revenue Market Share by Type (2017-2028)
4.3 Global Endoparasiticide Price by Type
4.3.1 Global Endoparasiticide Price by Type (2017-2022)
4.3.2 Global Endoparasiticide Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Endoparasiticide Sales by Application
5.1.1 Global Endoparasiticide Historical Sales by Application (2017-2022)
5.1.2 Global Endoparasiticide Forecasted Sales by Application (2023-2028)
5.1.3 Global Endoparasiticide Sales Market Share by Application (2017-2028)
5.2 Global Endoparasiticide Revenue by Application
5.2.1 Global Endoparasiticide Historical Revenue by Application (2017-2022)
5.2.2 Global Endoparasiticide Forecasted Revenue by Application (2023-2028)
5.2.3 Global Endoparasiticide Revenue Market Share by Application (2017-2028)
5.3 Global Endoparasiticide Price by Application
5.3.1 Global Endoparasiticide Price by Application (2017-2022)
5.3.2 Global Endoparasiticide Price Forecast by Application (2023-2028)
6 North America
6.1 North America Endoparasiticide Market Size by Type
6.1.1 North America Endoparasiticide Sales by Type (2017-2028)
6.1.2 North America Endoparasiticide Revenue by Type (2017-2028)
6.2 North America Endoparasiticide Market Size by Application
6.2.1 North America Endoparasiticide Sales by Application (2017-2028)
6.2.2 North America Endoparasiticide Revenue by Application (2017-2028)
6.3 North America Endoparasiticide Market Size by Country
6.3.1 North America Endoparasiticide Sales by Country (2017-2028)
6.3.2 North America Endoparasiticide Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Endoparasiticide Market Size by Type
7.1.1 Europe Endoparasiticide Sales by Type (2017-2028)
7.1.2 Europe Endoparasiticide Revenue by Type (2017-2028)
7.2 Europe Endoparasiticide Market Size by Application
7.2.1 Europe Endoparasiticide Sales by Application (2017-2028)
7.2.2 Europe Endoparasiticide Revenue by Application (2017-2028)
7.3 Europe Endoparasiticide Market Size by Country
7.3.1 Europe Endoparasiticide Sales by Country (2017-2028)
7.3.2 Europe Endoparasiticide Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Endoparasiticide Market Size by Type
8.1.1 Asia Pacific Endoparasiticide Sales by Type (2017-2028)
8.1.2 Asia Pacific Endoparasiticide Revenue by Type (2017-2028)
8.2 Asia Pacific Endoparasiticide Market Size by Application
8.2.1 Asia Pacific Endoparasiticide Sales by Application (2017-2028)
8.2.2 Asia Pacific Endoparasiticide Revenue by Application (2017-2028)
8.3 Asia Pacific Endoparasiticide Market Size by Region
8.3.1 Asia Pacific Endoparasiticide Sales by Region (2017-2028)
8.3.2 Asia Pacific Endoparasiticide Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Endoparasiticide Market Size by Type
9.1.1 Latin America Endoparasiticide Sales by Type (2017-2028)
9.1.2 Latin America Endoparasiticide Revenue by Type (2017-2028)
9.2 Latin America Endoparasiticide Market Size by Application
9.2.1 Latin America Endoparasiticide Sales by Application (2017-2028)
9.2.2 Latin America Endoparasiticide Revenue by Application (2017-2028)
9.3 Latin America Endoparasiticide Market Size by Country
9.3.1 Latin America Endoparasiticide Sales by Country (2017-2028)
9.3.2 Latin America Endoparasiticide Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Endoparasiticide Market Size by Type
10.1.1 Middle East and Africa Endoparasiticide Sales by Type (2017-2028)
10.1.2 Middle East and Africa Endoparasiticide Revenue by Type (2017-2028)
10.2 Middle East and Africa Endoparasiticide Market Size by Application
10.2.1 Middle East and Africa Endoparasiticide Sales by Application (2017-2028)
10.2.2 Middle East and Africa Endoparasiticide Revenue by Application (2017-2028)
10.3 Middle East and Africa Endoparasiticide Market Size by Country
10.3.1 Middle East and Africa Endoparasiticide Sales by Country (2017-2028)
10.3.2 Middle East and Africa Endoparasiticide Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Corporation Information
11.1.2 Boehringer Ingelheim Overview
11.1.3 Boehringer Ingelheim Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Boehringer Ingelheim Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Boehringer Ingelheim Recent Developments
11.2 Elanco
11.2.1 Elanco Corporation Information
11.2.2 Elanco Overview
11.2.3 Elanco Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Elanco Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Elanco Recent Developments
11.3 Zoetis
11.3.1 Zoetis Corporation Information
11.3.2 Zoetis Overview
11.3.3 Zoetis Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Zoetis Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Zoetis Recent Developments
11.4 Merck
11.4.1 Merck Corporation Information
11.4.2 Merck Overview
11.4.3 Merck Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Merck Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck Recent Developments
11.5 Virbac
11.5.1 Virbac Corporation Information
11.5.2 Virbac Overview
11.5.3 Virbac Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Virbac Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Virbac Recent Developments
11.6 Novartis AG
11.6.1 Novartis AG Corporation Information
11.6.2 Novartis AG Overview
11.6.3 Novartis AG Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Novartis AG Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Novartis AG Recent Developments
11.7 Ceva Sante Animlae
11.7.1 Ceva Sante Animlae Corporation Information
11.7.2 Ceva Sante Animlae Overview
11.7.3 Ceva Sante Animlae Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Ceva Sante Animlae Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ceva Sante Animlae Recent Developments
11.8 Bayer AG
11.8.1 Bayer AG Corporation Information
11.8.2 Bayer AG Overview
11.8.3 Bayer AG Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Bayer AG Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bayer AG Recent Developments
11.9 Eli Lilly
11.9.1 Eli Lilly Corporation Information
11.9.2 Eli Lilly Overview
11.9.3 Eli Lilly Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Eli Lilly Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Eli Lilly Recent Developments
11.10 Vetoquinol
11.10.1 Vetoquinol Corporation Information
11.10.2 Vetoquinol Overview
11.10.3 Vetoquinol Endoparasiticide Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Vetoquinol Endoparasiticide Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Vetoquinol Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Endoparasiticide Industry Chain Analysis
12.2 Endoparasiticide Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Endoparasiticide Production Mode & Process
12.4 Endoparasiticide Sales and Marketing
12.4.1 Endoparasiticide Sales Channels
12.4.2 Endoparasiticide Distributors
12.5 Endoparasiticide Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Endoparasiticide Industry Trends
13.2 Endoparasiticide Market Drivers
13.3 Endoparasiticide Market Challenges
13.4 Endoparasiticide Market Restraints
14 Key Findings in The Global Endoparasiticide Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
